Christopher Laing, MRCVS, PhD
Chris Laing oversees the Science Center’s Science and Technology Programs, including the Port business incubators and the QED Proof-of-Concept Program. He also provides direct R&D strategy support to Science Center Port business incubator companies and facilitates their access to Greater Philadelphia’s academic and clinical communities through the Science Center’s Scientific Advisory Committee for the Board of Directors.
Chris began working with the Science Center as a consultant in 2004 and joined the staff as Director of Science & Technology in 2006. He was promoted to Vice President, Science and Technology in May 2010. He has helped numerous Science Center business clients turn their academic research into thriving businesses. Chris provides guidance in early business and product development planning, in securing the resources required to retire early technology risks, and in providing a technical communication stream that includes publications, marketing, and applications to federal agencies including NIH, NSF, and FDA.
Chris has helped raise more than $20 million in equity-sparing federal funding to directly support product development by small technology companies. His expertise includes experience in the commercial development of a wide range of technologies, including drugs and biologicals, medical devices, diagnostics, and research tools.
Chris has a Ph.D. in molecular endocrinology, and completed his post-doctoral training at the University of Pennsylvania’s School of Medicine. He is a Member of the Royal College of Veterinary Surgeons in the United Kingdom.